The DOI matches its Crossref record; 457 of the 457 references it cites were found in a registry or an index.
Bacterial persisters: molecular mechanisms and therapeutic development
Open accessAbstract
Persisters refer to genetically drug susceptible quiescent (non-growing or slow growing) bacteria that survive in stress environments such as antibiotic exposure, acidic and starvation conditions. These cells can regrow after stress removal and remain susceptible to the same stress. Persisters are underlying the problems of treating chronic and persistent infections and relapse infections after treatment, drug resistance development, and biofilm infections, and pose significant challenges for effective treatments. Understanding the characteristics and the exact mechanisms of persister formation, especially the key molecules that affect the formation and survival of the persisters is critical to more effective treatment of chronic and persistent infections. Currently, genes related to persister formation and survival are being discovered and confirmed, but the mechanisms by which bacteria form persisters are very complex, and there are still many unanswered questions. This article comprehensively summarizes the historical background of bacterial persisters, details their complex characteristics and their relationship with antibiotic tolerant and resistant bacteria, systematically elucidates the interplay between various bacterial biological processes and the formation of persister cells, as well as consolidates the diverse anti-persister compounds and treatments. We hope to provide theoretical background for in-depth research on mechanisms of persisters and suggest new ideas for choosing strategies for more effective treatment of persistent infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
RETRACTED: Bacterial persistence by RNA endonucleases
Maisonneuve, E., Shakespeare, L. J., Jørgensen, M. G., & Gerdes, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100186108 · Cited by 475
RetractedMaisonneuve, E., Castro-Camargo, M., & Gerdes, K. (2013) · Cell · doi:10.1016/j.cell.2013.07.048 · Cited by 438
RetractedGermain, E., Roghanian, M., Gerdes, K., & Maisonneuve, E. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423536112 · Cited by 177
RetractedBacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167 · cited 2×
“82,83 It was then discovered that bio fi lms contain persisters which are subsequently recognized as the culprit for the dif fi culty in curing bio fi lm infections, relapse after treatment, and other chronic persistent infections.”
BackgroundConstruction of Escherichia coli K‐12 in‐frame, single‐gene knockout mutants: the Keio collection
Baba, T., Ara, T., Hasegawa, M., Takai, Y., Okumura, Y., Baba, M., Datsenko, K. A., Tomita, M., Wanner, B. L., & Mori, H. (2006) · Molecular Systems Biology · doi:10.1038/msb4100050 · Cited by 7,858
Wiegand, I., Hilpert, K., & Hancock, R. E. W. (2008) · Nature Protocols · doi:10.1038/nprot.2007.521 · Cited by 6,156
Bacterial Persistence as a Phenotypic Switch
Balaban, N. Q., Merrin, J., Chait, R., Kowalik, L., & Leibler, S. (2004) · Science · doi:10.1126/science.1099390 · Cited by 2,952 · cited 5×
“25 In fact, the metabolic heterogeneity of persisters is much more complex than that of type I and type II persisters.”
BackgroundInfluentialDrugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512
Antibiotics: past, present and future
Hutchings, M. I., Truman, A. W., & Wilkinson, B. (2019) · Current Opinion in Microbiology · doi:10.1016/j.mib.2019.10.008 · Cited by 2,370
Quorum sensing signal-response systems in Gram-negative bacteria
Papenfort, K., & Bassler, B. L. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.89 · Cited by 2,256
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
Andries, K., Verhasselt, P., Guillemont, J., Göhlmann, H. W. H., Neefs, J.-M., Winkler, H., Van Gestel, J., Timmerman, P., Zhu, M., Lee, E., et al. (2005) · Science · doi:10.1126/science.1106753 · Cited by 2,191 · cited 1×
“377 Research has shown that when combined with other agents such as pretomanid and moxi fl ox-acin, bedaquiline effectively eliminates M. tuberculosis in non-replicating persister state.”
BackgroundFinzi, D., Blankson, J., Siliciano, J. D., Margolick, J. B., Chadwick, K., Pierson, T., Smith, K., Lisziewicz, J., Lori, F., Flexner, C., et al. (1999) · Nature Medicine · doi:10.1038/8394 · Cited by 2,119 · cited 1×
“In the following clinical treatment of challenging persistent infections like tuberculosis 17,378 and acquired immune de fi ciency syndrome (AIDS), 475,476 combination therapies with multiple drugs are employed, which may also be the most effective approach for treating other persistent infections.”
BackgroundPersister cells, dormancy and infectious disease
Lewis, K. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1557 · Cited by 2,052 · cited 4×
“84,125 A notable illustration of this challenge is evident in bio fi lm infections caused by P. aeruginosa and M. abscessus among individuals with cystic fi brosis.”
BackgroundInfluentialLewis, K. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.999-1007.2001 · Cited by 1,980
Lewis, K. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134306 · Cited by 1,858
A brief history of the antibiotic era: lessons learned and challenges for the future
Aminov, R. I. (2010) · Frontiers in Microbiology · doi:10.3389/fmicb.2010.00134 · Cited by 1,628
Distinguishing between resistance, tolerance and persistence to antibiotic treatment
Brauner, A., Fridman, O., Gefen, O., & Balaban, N. Q. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.34 · Cited by 1,612
Multidrug-resistance efflux pumps ? not just for resistance
Piddock, L. J. V. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1464 · Cited by 1,522
Dedrick, R. M., Guerrero-Bustamante, C. A., Garlena, R. A., Russell, D. A., Ford, K., Harris, K., Gilmour, K. C., Soothill, J., Jacobs-Sera, D., Schooley, R. T., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0437-z · Cited by 1,410
Betts, J. C., Lukey, P. T., Robb, L. C., McAdam, R. A., & Duncan, K. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02779.x · Cited by 1,395
Definitions and guidelines for research on antibiotic persistence
Balaban, N. Q., Helaine, S., Lewis, K., Ackermann, M., Aldridge, B., Andersson, D. I., Brynildsen, M. P., Bumann, D., Camilli, A., Collins, J. J., et al. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0196-3 · Cited by 1,313 · cited 1×
“%) to survive antibiotic exposure, while tolerance describes the same ability but pertains an entire bacterial population 85,137 (Fig.”
BackgroundThe Cytosolic DNA-Sensing cGAS–STING Pathway in Cancer
Kwon, J., & Bakhoum, S. F. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0761 · Cited by 1,293
Antibiotic tolerance facilitates the evolution of resistance
Levin-Reisman, I., Ronin, I., Gefen, O., Braniss, I., Shoresh, N., & Balaban, N. Q. (2017) · Science · doi:10.1126/science.aaj2191 · Cited by 1,251
Persistent bacterial infections and persister cells
Fisher, R. A., Gollan, B., & Helaine, S. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.42 · Cited by 1,243 · cited 2×
“14,27,28 For instance, Fisher et al. had summarized the correlation between persistent bacteria and clinical diseases, with focuses on the mechanisms of bacterial persistence in toxin-antitoxin modules, stringent response, bacterial communication, drug ef fl ux, and others.”
BackgroundRecent findings on the viable but nonculturable state in pathogenic bacteria
Oliver, J. D. (2010) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2009.00200.x · Cited by 1,203
SOS response promotes horizontal dissemination of antibiotic resistance genes
Beaber, J. W., Hochhut, B., & Waldor, M. K. (2004) · Nature · doi:10.1038/nature02241 · Cited by 1,186
TREATMENT OF STAPHYLOCOCCAL INFECTIONS WITH PENICILLIN BY INTERMITTENT STERILISATION
Bigger, J. (1944) · The Lancet · doi:10.1016/s0140-6736(00)74210-3 · Cited by 1,178
Proctor, R. A., von Eiff, C., Kahl, B. C., Becker, K., McNamara, P., Herrmann, M., & Peters, G. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1384 · Cited by 1,175 · cited 1×
“109,117,118 These small colonies represent a subpopulation of persister cells with an extended bacterial lag phase, 119 and their frequency within a bacterial population tends to increase following exposure to stressors such as acidic pH 120 or reactive oxygen species.”
BackgroundPotrykus, K., & Cashel, M. (2008) · Annual Review of Microbiology · doi:10.1146/annurev.micro.62.081307.162903 · Cited by 1,165
Intracellular Bacterial Biofilm-Like Pods in Urinary Tract Infections
Anderson, G. G., Palermo, J. J., Schilling, J. D., Roth, R., Heuser, J., & Hultgren, S. J. (2003) · Science · doi:10.1126/science.1084550 · Cited by 1,161
Persister cells and tolerance to antimicrobials
Keren, I., Kaldalu, N., Spoering, A., Wang, Y., & Lewis, K. (2004) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(03)00856-5 · Cited by 1,098
Xu, H. S., Roberts, N., Singleton, F. L., Attwell, R. W., Grimes, D. J., & Colwell, R. R. (1982) · Microbial Ecology · doi:10.1007/bf02010671 · Cited by 1,098
Indole as an intercellular signal in microbial communities
Lee, J.-H., & Lee, J. (2010) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2009.00204.x · Cited by 1,059
Multidrug efflux pumps: structure, function and regulation
Du, D., Wang-Kan, X., Neuberger, A., van Veen, H. W., Pos, K. M., Piddock, L. J. V., & Luisi, B. F. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0048-6 · Cited by 1,055
Metabolite-enabled eradication of bacterial persisters by aminoglycosides
Allison, K. R., Brynildsen, M. P., & Collins, J. J. (2011) · Nature · doi:10.1038/nature10069 · Cited by 1,025 · cited 1×
“Currently, there are several compounds that sensitize persister cells, such as cis-2-decenoic acid, 455 carbon metabolites, 248,459,460 amino acids, 242,283,464,465 metal ions, 466,489 and others.”
BackgroundBassler, B. L., & Losick, R. (2006) · Cell · doi:10.1016/j.cell.2006.04.001 · Cited by 983
Active Starvation Responses Mediate Antibiotic Tolerance in Biofilms and Nutrient-Limited Bacteria
Nguyen, D., Joshi-Datar, A., Lepine, F., Bauerle, E., Olakanmi, O., Beer, K., McKay, G., Siehnel, R., Schafhauser, J., Wang, Y., et al. (2011) · Science · doi:10.1126/science.1211037 · Cited by 978
Escherichia coli acid resistance: tales of an amateur acidophile
Foster, J. W. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro1021 · Cited by 966
Mechanisms of bacterial persistence during stress and antibiotic exposure
Harms, A., Maisonneuve, E., & Gerdes, K. (2016) · Science · doi:10.1126/science.aaf4268 · Cited by 919
Spoering, A. L., & Lewis, K. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.23.6746-6751.2001 · Cited by 902
Hurdle, J. G., O'Neill, A. J., Chopra, I., & Lee, R. E. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2474 · Cited by 871
Specialized Persister Cells and the Mechanism of Multidrug Tolerance in Escherichia coli
Keren, I., Shah, D., Spoering, A., Kaldalu, N., & Lewis, K. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.24.8172-8180.2004 · Cited by 856
Courcelle, J., Khodursky, A., Peter, B., Brown, P. O., & Hanawalt, P. C. (2001) · Genetics · doi:10.1093/genetics/158.1.41 · Cited by 853
Antibiotic resistance and persistence—implications for human health and treatment perspectives
Huemer, M., Mairpady Shambat, S., Brugger, S. D., & Zinkernagel, A. S. (2020) · The EMBO Reports · doi:10.15252/embr.202051034 · Cited by 850
Drug combinations: a strategy to extend the life of antibiotics in the 21st century
Tyers, M., & Wright, G. D. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0141-x · Cited by 820
Phage therapy: From biological mechanisms to future directions
Strathdee, S. A., Hatfull, G. F., Mutalik, V. K., & Schooley, R. T. (2023) · Cell · doi:10.1016/j.cell.2022.11.017 · Cited by 817 · cited 2×
“433 However, the challenges of phage therapy include insuf fi cient pharmacokinetic and pharma-codynamic studies, the need for further evaluation of clinical ef fi cacy, and the management of foreign proteins, nucleic acids, and virulence factors introduced by phages, all of which pose signi fi cant…”
BackgroundRecent functional insights into the role of (p)ppGpp in bacterial physiology
Hauryliuk, V., Atkinson, G. C., Murakami, K. S., Tenson, T., & Gerdes, K. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3448 · Cited by 790
Ciprofloxacin Causes Persister Formation by Inducing the TisB toxin in Escherichia coli
Dörr, T., Vulić, M., & Lewis, K. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000317 · Cited by 782
H 2 S: A Universal Defense Against Antibiotics in Bacteria
Shatalin, K., Shatalina, E., Mironov, A., & Nudler, E. (2011) · Science · doi:10.1126/science.1209855 · Cited by 766
Silver Enhances Antibiotic Activity Against Gram-Negative Bacteria
Morones-Ramirez, J. R., Winkler, J. A., Spina, C. S., & Collins, J. J. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006276 · Cited by 756
Surviving as a Community: Antibiotic Tolerance and Persistence in Bacterial Biofilms
Yan, J., & Bassler, B. L. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.06.002 · Cited by 747
Internalization of Salmonella by Macrophages Induces Formation of Nonreplicating Persisters
Helaine, S., Cheverton, A. M., Watson, K. G., Faure, L. M., Matthews, S. A., & Holden, D. W. (2014) · Science · doi:10.1126/science.1244705 · Cited by 742
ESCMID∗ guideline for the diagnosis and treatment of biofilm infections 2014
Høiby, N., Bjarnsholt, T., Moser, C., Bassi, G. L., Coenye, T., Donelli, G., Hall-Stoodley, L., Holá, V., Imbert, C., Kirketerp-Møller, K., et al. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.10.024 · Cited by 726
Scorpio, A., & Zhang, Y. (1996) · Nature Medicine · doi:10.1038/nm0696-662 · Cited by 726
Self-citationThe curious characteristics of pyrazinamide: a review.
Zhang, Y., & Mitchison, D. A. (2003) · PubMed · Cited by 723
Self-citationToxin-antitoxin systems in bacterial growth arrest and persistence
Page, R., & Peti, W. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2044 · Cited by 702
Activated ClpP kills persisters and eradicates a chronic biofilm infection
Conlon, B. P., Nakayasu, E. S., Fleck, L. E., LaFleur, M. D., Isabella, V. M., Coleman, K., Leonard, S. N., Smith, R. D., Adkins, J. N., & Lewis, K. (2013) · Nature · doi:10.1038/nature12790 · Cited by 672
Persister formation in Staphylococcus aureus is associated with ATP depletion
Conlon, B. P., Rowe, S. E., Gandt, A. B., Nuxoll, A. S., Donegan, N. P., Zalis, E. A., Clair, G., Adkins, J. N., Cheung, A. L., & Lewis, K. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.51 · Cited by 671
The past, present, and future of antibiotics
Cook, M. A., & Wright, G. D. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abo7793 · Cited by 652
Molecular Mechanisms Underlying Bacterial Persisters
Maisonneuve, E., & Gerdes, K. (2014) · Cell · doi:10.1016/j.cell.2014.02.050 · Cited by 645
Bacterial charity work leads to population-wide resistance
Lee, H. H., Molla, M. N., Cantor, C. R., & Collins, J. J. (2010) · Nature · doi:10.1038/nature09354 · Cited by 638 · cited 1×
“328,329 These research fi ndings have established the relationship between quorum sensing, reactive oxygen species (ROS), and ef fl ux pumps (Fig.”
BackgroundToxins, Targets, and Triggers: An Overview of Toxin-Antitoxin Biology
Harms, A., Brodersen, D. E., Mitarai, N., & Gerdes, K. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.01.003 · Cited by 638
Justice, S. S., Hung, C., Theriot, J. A., Fletcher, D. A., Anderson, G. G., Footer, M. J., & Hultgren, S. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308125100 · Cited by 632
Mulcahy, L. R., Burns, J. L., Lory, S., & Lewis, K. (2010) · Journal of Bacteriology · doi:10.1128/jb.01651-09 · Cited by 631
Persisters: a distinct physiological state of E. coli
Shah, D., Zhang, Z., Khodursky, A. B., Kaldalu, N., Kurg, K., & Lewis, K. (2006) · BMC Microbiology · doi:10.1186/1471-2180-6-53 · Cited by 629
Moyed, H. S., & Bertrand, K. P. (1983) · Journal of Bacteriology · doi:10.1128/jb.155.2.768-775.1983 · Cited by 625
Has the era of untreatable infections arrived?
Livermore, D. M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp255 · Cited by 620
Welsh, D. (2000) · FEMS Microbiology Reviews · doi:10.1016/s0168-6445(99)00038-8 · Cited by 603
Quinolone-Mediated Bacterial Death
Drlica, K., Malik, M., Kerns, R. J., & Zhao, X. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01617-06 · Cited by 570
Identification of additional genes belonging to the LexA regulon in Escherichia coli
Fernández de Henestrosa, A. R., Ogi, T., Aoyagi, S., Chafin, D., Hayes, J. J., Ohmori, H., & Woodgate, R. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.01826.x · Cited by 570
Dynamic Persistence of Antibiotic-Stressed Mycobacteria
Wakamoto, Y., Dhar, N., Chait, R., Schneider, K., Signorino-Gelo, F., Leibler, S., & McKinney, J. D. (2013) · Science · doi:10.1126/science.1229858 · Cited by 542
Non-inherited antibiotic resistance
Levin, B. R., & Rozen, D. E. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1445 · Cited by 542
Mwangi, M. M., Wu, S. W., Zhou, Y., Sieradzki, K., de Lencastre, H., Richardson, P., Bruce, D., Rubin, E., Myers, E., Siggia, E. D., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609839104 · Cited by 538
SOS Response Induces Persistence to Fluoroquinolones in Escherichia coli
Dörr, T., Lewis, K., & Vulić, M. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000760 · Cited by 534
Drug Tolerance in Replicating Mycobacteria Mediated by a Macrophage-Induced Efflux Mechanism
Adams, K. N., Takaki, K., Connolly, L. E., Wiedenhoft, H., Winglee, K., Humbert, O., Edelstein, P. H., Cosma, C. L., & Ramakrishnan, L. (2011) · Cell · doi:10.1016/j.cell.2011.02.022 · Cited by 530
Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy
Lu, T. K., & Collins, J. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800442106 · Cited by 529
Persister cells and the riddle of biofilm survival
Lewis, K. (2005) · Biochemistry (Moscow) · doi:10.1007/s10541-005-0111-6 · Cited by 520
Pyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosis
Shi, W., Zhang, X., Jiang, X., Yuan, H., Lee, J. S., Barry, C. E., Wang, H., Zhang, W., & Zhang, Y. (2011) · Science · doi:10.1126/science.1208813 · Cited by 514
Self-citationATP-Dependent Persister Formation in Escherichia coli
Shan, Y., Brown Gandt, A., Rowe, S. E., Deisinger, J. P., Conlon, B. P., & Lewis, K. (2017) · mBio · doi:10.1128/mbio.02267-16 · Cited by 508 · cited 2×
“26,186 This method also has certain disadvantages, such as the environment and density of the bacteria are changed after the sorted persisters are transferred to a new buffer or medium.”
BackgroundDysregulation of bacterial proteolytic machinery by a new class of antibiotics
Brötz-Oesterhelt, H., Beyer, D., Kroll, H.-P., Endermann, R., Ladel, C., Schroeder, W., Hinzen, B., Raddatz, S., Paulsen, H., Henninger, K., et al. (2005) · Nature Medicine · doi:10.1038/nm1306 · Cited by 505
Stecher, B., Denzler, R., Maier, L., Bernet, F., Sanders, M. J., Pickard, D. J., Barthel, M., Westendorf, A. M., Krogfelt, K. A., Walker, A. W., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113246109 · Cited by 492 · cited 1×
“170,171 For example, the SOS response increase the frequency of horizontal gene transfer in E. coli and V. cholerae , speci fi cally facilitating the exchange of resistance elements for aminoglycosides, lincosamides, and antifolate antibiotics.”
BackgroundEffect of tolerance on the evolution of antibiotic resistance under drug combinations
Liu, J., Gefen, O., Ronin, I., Bar-Meir, M., & Balaban, N. Q. (2020) · Science · doi:10.1126/science.aay3041 · Cited by 485
Therapy of tuberculosis in mice by DNA vaccination
Lowrie, D. B., Tascon, R. E., Bonato, V. L. D., Lima, V. M. F., Faccioli, L. H., Stavropoulos, E., Colston, M. J., Hewinson, R. G., Moelling, K., & Silva, C. L. (1999) · Nature · doi:10.1038/22326 · Cited by 474
Microbial Persistence and the Road to Drug Resistance
Cohen, N. R., Lobritz, M. A., & Collins, J. J. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.05.009 · Cited by 460
SOS, the formidable strategy of bacteria against aggressions
Baharoglu, Z., & Mazel, D. (2014) · FEMS Microbiology Reviews · doi:10.1111/1574-6976.12077 · Cited by 457
Observations on the Mechanism of Action of Penicillin.
Hobby, G. L., Meyer, K., & Chaffee, E. (1942) · Experimental Biology and Medicine · doi:10.3181/00379727-50-13773 · Cited by 444
Multiple Antibiotic Resistance in a Bacterium with Suppressed Autolytic System
TOMASZ, A., ALBINO, A., & ZANATI, E. (1970) · Nature · doi:10.1038/227138a0 · Cited by 429
Fauvart, M., De Groote, V. N., & Michiels, J. (2011) · Journal of Medical Microbiology · doi:10.1099/jmm.0.030932-0 · Cited by 425 · cited 1×
“…chronic persistent bacterial infections have been extensively studied in urinary tract infections, tuberculosis, endocarditis, refractory cystic fi brosis infections, 21,84,155,156 as well as indwelling device-related infections like pacemaker-related infections and prosthetic joint infections.”
BackgroundGavrish, E., Sit, C. S., Cao, S., Kandror, O., Spoering, A., Peoples, A., Ling, L., Fetterman, A., Hughes, D., Bissell, A., et al. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.01.014 · Cited by 423
Endogenous Nitric Oxide Protects Bacteria Against a Wide Spectrum of Antibiotics
Gusarov, I., Shatalin, K., Starodubtseva, M., & Nudler, E. (2009) · Science · doi:10.1126/science.1175439 · Cited by 417
Signaling-mediated bacterial persister formation
Vega, N. M., Allison, K. R., Khalil, A. S., & Collins, J. J. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.915 · Cited by 414
A new class of synthetic retinoid antibiotics effective against bacterial persisters
Kim, W., Zhu, W., Hendricks, G. L., Van Tyne, D., Steele, A. D., Keohane, C. E., Fricke, N., Conery, A. L., Shen, S., Pan, W., et al. (2018) · Nature · doi:10.1038/nature26157 · Cited by 411
Characterization and Transcriptome Analysis of Mycobacterium tuberculosis Persisters
Keren, I., Minami, S., Rubin, E., & Lewis, K. (2011) · mBio · doi:10.1128/mbio.00100-11 · Cited by 404
Molecular Mechanism of Bacterial Persistence by HipA
Germain, E., Castro-Roa, D., Zenkin, N., & Gerdes, K. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.08.045 · Cited by 392
Intracellular Staphylococcus aureus persisters upon antibiotic exposure
Peyrusson, F., Varet, H., Nguyen, T. K., Legendre, R., Sismeiro, O., Coppée, J.-Y., Wolz, C., Tenson, T., & Van Bambeke, F. (2020) · Nature Communications · doi:10.1038/s41467-020-15966-7 · Cited by 392
Pu, Y., Li, Y., Jin, X., Tian, T., Ma, Q., Zhao, Z., Lin, S.-Y., Chen, Z., Li, B., Yao, G., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2018.10.022 · Cited by 390
Bacterial Persistence and Toxin-Antitoxin Loci
Gerdes, K., & Maisonneuve, E. (2012) · Annual Review of Microbiology · doi:10.1146/annurev-micro-092611-150159 · Cited by 387
Enhanced Efflux Activity Facilitates Drug Tolerance in Dormant Bacterial Cells
Pu, Y., Zhao, Z., Li, Y., Zou, J., Ma, Q., Zhao, Y., Ke, Y., Zhu, Y., Chen, H., Baker, M. A. B., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.03.035 · Cited by 381
Meylan, S., Porter, C. B. M., Yang, J. H., Belenky, P., Gutierrez, A., Lobritz, M. A., Park, J., Kim, S. H., Moskowitz, S. M., & Collins, J. J. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2016.12.015 · Cited by 377
Transcription Profiling of the Stringent Response in Escherichia coli
Durfee, T., Hansen, A.-M., Zhi, H., Blattner, F. R., & Jin, D. J. (2008) · Journal of Bacteriology · doi:10.1128/jb.01092-07 · Cited by 374
Arrested Protein Synthesis Increases Persister-Like Cell Formation
Kwan, B. W., Valenta, J. A., Benedik, M. J., & Wood, T. K. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02135-12 · Cited by 367
Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes
Lieberman, T. D., Michel, J.-B., Aingaran, M., Potter-Bynoe, G., Roux, D., Davis, M. R., Skurnik, D., Leiby, N., LiPuma, J. J., Goldberg, J. B., et al. (2011) · Nature Genetics · doi:10.1038/ng.997 · Cited by 365
Molecular Mechanisms of HipA-Mediated Multidrug Tolerance and Its Neutralization by HipB
Schumacher, M. A., Piro, K. M., Xu, W., Hansen, S., Lewis, K., & Brennan, R. G. (2009) · Science · doi:10.1126/science.1163806 · Cited by 351 · cited 1×
“26 – 241 However, the knockout of cumulative deletion of 10 TA modules or more decreases tolerance to antibiotics, but single deletions had no effect on persister levels, 226,242 which may be due to the abundance of TA elements in bacteria.”
BackgroundBacteriophage-resistant Acinetobacter baumannii are resensitized to antimicrobials
Gordillo Altamirano, F., Forsyth, J. H., Patwa, R., Kostoulias, X., Trim, M., Subedi, D., Archer, S. K., Morris, F. C., Oliveira, C., Kielty, L., et al. (2021) · Nature Microbiology · doi:10.1038/s41564-020-00830-7 · Cited by 349
Dedrick, R. M., Smith, B. E., Cristinziano, M., Freeman, K. G., Jacobs-Sera, D., Belessis, Y., Whitney Brown, A., Cohen, K. A., Davidson, R. M., van Duin, D., et al. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciac453 · Cited by 344
Toxin–antitoxin systems: Biology, identification, and application
Unterholzner, S. J., Poppenberger, B., & Rozhon, W. (2013) · Mobile Genetic Elements · doi:10.4161/mge.26219 · Cited by 334
Mechanisms of Pyrazinamide Action and Resistance
Zhang, Y., Shi, W., Zhang, W., & Mitchison, D. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.mgm2-0023-2013 · Cited by 332
Self-citationThe Stringent Response of Mycobacterium tuberculosis Is Required for Long-Term Survival
Primm, T. P., Andersen, S. J., Mizrahi, V., Avarbock, D., Rubin, H., & Barry, C. E. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.17.4889-4898.2000 · Cited by 332
Indole induces the expression of multidrug exporter genes in Escherichia coli
Hirakawa, H., Inazumi, Y., Masaki, T., Hirata, T., & Yamaguchi, A. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04449.x · Cited by 328
Kahl, B. C., Becker, K., & Löffler, B. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00069-15 · Cited by 325
Salmonella chronic carriage: epidemiology, diagnosis, and gallbladder persistence
Gunn, J. S., Marshall, J. M., Baker, S., Dongol, S., Charles, R. C., & Ryan, E. T. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2014.06.007 · Cited by 321
Verstraeten, N., Knapen, W. J., Kint, C. I., Liebens, V., Van den Bergh, B., Dewachter, L., Michiels, J. E., Fu, Q., David, C. C., Fierro, A. C., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.05.011 · Cited by 320
Phenotypic Variation of Salmonella in Host Tissues Delays Eradication by Antimicrobial Chemotherapy
Claudi, B., Spröte, P., Chirkova, A., Personnic, N., Zankl, J., Schürmann, N., Schmidt, A., & Bumann, D. (2014) · Cell · doi:10.1016/j.cell.2014.06.045 · Cited by 316
The importance of being persistent: heterogeneity of bacterial populations under antibiotic stress
Gefen, O., & Balaban, N. Q. (2009) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2008.00156.x · Cited by 315
Role of Global Regulators and Nucleotide Metabolism in Antibiotic Tolerance in Escherichia coli
Hansen, S., Lewis, K., & Vulić, M. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00144-08 · Cited by 300
Mechanistic insights into bacterial AAA+ proteases and protein-remodelling machines
Olivares, A. O., Baker, T. A., & Sauer, R. T. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2015.4 · Cited by 290
Frees, D., Savijoki, K., Varmanen, P., & Ingmer, H. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05598.x · Cited by 288
Eskenazi, A., Lood, C., Wubbolts, J., Hites, M., Balarjishvili, N., Leshkasheli, L., Askilashvili, L., Kvachadze, L., van Noort, V., Wagemans, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27656-z · Cited by 287
Relationship between the Viable but Nonculturable State and Antibiotic Persister Cells
Ayrapetyan, M., Williams, T., & Oliver, J. D. (2018) · Journal of Bacteriology · doi:10.1128/jb.00249-18 · Cited by 286
Transduction of envelope stress in Escherichia coli by the Cpx two-component system
Raivio, T. L., & Silhavy, T. J. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.24.7724-7733.1997 · Cited by 281
De Biase, D., Tramonti, A., Bossa, F., & Visca, P. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01430.x · Cited by 280
Bacterial Persisters and Infection: Past, Present, and Progressing
Gollan, B., Grabe, G., Michaux, C., & Helaine, S. (2019) · Annual Review of Microbiology · doi:10.1146/annurev-micro-020518-115650 · Cited by 280
Toxins-antitoxins: diversity, evolution and function
Hayes, F., & Van Melderen, L. (2011) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2011.600437 · Cited by 277
Mascio, C. T. M., Alder, J. D., & Silverman, J. A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00824-07 · Cited by 276
Cirz, R. T., O'Neill, B. M., Hammond, J. A., Head, S. R., & Romesberg, F. E. (2006) · Journal of Bacteriology · doi:10.1128/jb.00807-06 · Cited by 276
Van den Bergh, B., Michiels, J. E., Wenseleers, T., Windels, E. M., Boer, P. V., Kestemont, D., De Meester, L., Verstrepen, K. J., Verstraeten, N., Fauvart, M., et al. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.20 · Cited by 276
Complete and SOS-Mediated Response of Staphylococcus aureus to the Antibiotic Ciprofloxacin
Cirz, R. T., Jones, M. B., Gingles, N. A., Minogue, T. D., Jarrahi, B., Peterson, S. N., & Romesberg, F. E. (2007) · Journal of Bacteriology · doi:10.1128/jb.01464-06 · Cited by 273
Starkey, M., Lepine, F., Maura, D., Bandyopadhaya, A., Lesic, B., He, J., Kitao, T., Righi, V., Milot, S., Tzika, A., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004321 · Cited by 273
Targeting Persisters for Tuberculosis Control
Zhang, Y., Yew, W. W., & Barer, M. R. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06288-11 · Cited by 271
Self-citationHipA-mediated antibiotic persistence via phosphorylation of the glutamyl-tRNA-synthetase
Kaspy, I., Rotem, E., Weiss, N., Ronin, I., Balaban, N. Q., & Glaser, G. (2013) · Nature Communications · doi:10.1038/ncomms4001 · Cited by 268
A problem of persistence: still more questions than answers?
Balaban, N. Q., Gerdes, K., Lewis, K., & McKinney, J. D. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3076 · Cited by 263
Bernier, S. P., Lebeaux, D., DeFrancesco, A. S., Valomon, A., Soubigou, G., Coppée, J.-Y., Ghigo, J.-M., & Beloin, C. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003144 · Cited by 262
Role of AcrAB-TolC multidrug efflux pump in drug-resistance acquisition by plasmid transfer
Nolivos, S., Cayron, J., Dedieu, A., Page, A., Delolme, F., & Lesterlin, C. (2019) · Science · doi:10.1126/science.aav6390 · Cited by 257
Salmonella persisters promote the spread of antibiotic resistance plasmids in the gut
Bakkeren, E., Huisman, J. S., Fattinger, S. A., Hausmann, A., Furter, M., Egli, A., Slack, E., Sellin, M. E., Bonhoeffer, S., Regoes, R. R., et al. (2019) · Nature · doi:10.1038/s41586-019-1521-8 · Cited by 255
Nick, J. A., Dedrick, R. M., Gray, A. L., Vladar, E. K., Smith, B. E., Freeman, K. G., Malcolm, K. C., Epperson, L. E., Hasan, N. A., Hendrix, J., et al. (2022) · Cell · doi:10.1016/j.cell.2022.04.024 · Cited by 251
Möker, N., Dean, C. R., & Tao, J. (2010) · Journal of Bacteriology · doi:10.1128/jb.01231-09 · Cited by 245
Antitoxin MqsA helps mediate the bacterial general stress response
Wang, X., Kim, Y., Hong, S. H., Ma, Q., Brown, B. L., Pu, M., Tarone, A. M., Benedik, M. J., Peti, W., Page, R., et al. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.560 · Cited by 244
Podlesek, Z., & Žgur Bertok, D. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01785 · Cited by 242
Keiler, K. C. (2008) · Annual Review of Microbiology · doi:10.1146/annurev.micro.62.081307.162948 · Cited by 235
A Salmonella Toxin Promotes Persister Formation through Acetylation of tRNA
Cheverton, A. M., Gollan, B., Przydacz, M., Wong, C. T., Mylona, A., Hare, S. A., & Helaine, S. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.05.002 · Cited by 235
Persisters, persistent infections and the Yin–Yang model
Zhang, Y. (2014) · Emerging Microbes & Infections · doi:10.1038/emi.2014.3 · Cited by 233
Self-citationVázquez-Laslop, N., Lee, H., & Neyfakh, A. A. (2006) · Journal of Bacteriology · doi:10.1128/jb.188.10.3494-3497.2006 · Cited by 231
Dewachter, L., Fauvart, M., & Michiels, J. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.09.028 · Cited by 230
Stallings, C. L., Stephanou, N. C., Chu, L., Hochschild, A., Nickels, B. E., & Glickman, M. S. (2009) · Cell · doi:10.1016/j.cell.2009.04.041 · Cited by 225
Identity and function of a large gene network underlying mutagenic repair of DNA breaks
Al Mamun, A. A. M., Lombardo, M.-J., Shee, C., Lisewski, A. M., Gonzalez, C., Lin, D., Nehring, R. B., Saint-Ruf, C., Gibson, J. L., Frisch, R. L., et al. (2012) · Science · doi:10.1126/science.1226683 · Cited by 224
Glutamine promotes antibiotic uptake to kill multidrug-resistant uropathogenic bacteria
Zhao, X.-L., Chen, Z.-G., Yang, T.-C., Jiang, M., Wang, J., Cheng, Z.-X., Yang, M.-J., Zhu, J.-X., Zhang, T.-T., Li, H., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abj0716 · Cited by 224
Fighting bacterial persistence: Current and emerging anti-persister strategies and therapeutics
Defraine, V., Fauvart, M., & Michiels, J. (2018) · Drug Resistance Updates · doi:10.1016/j.drup.2018.03.002 · Cited by 222 · cited 1×
“Encouragingly, with the advancement of our understanding of mechanisms and characteristics of persisters, several anti-persister compounds have been discovered 89,372,373 (Table 2).”
BackgroundLi, Y., & Zhang, Y. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00052-07 · Cited by 222
Self-citationThe antibiotic ADEP reprogrammes ClpP, switching it from a regulated to an uncontrolled protease
Kirstein, J., Hoffmann, A., Lilie, H., Schmidt, R., Rübsamen‐Waigmann, H., Brötz‐Oesterhelt, H., Mogk, A., & Turgay, K. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900002 · Cited by 220
Role of quorum sensing in bacterial infections
Castillo-Juárez, I., Maeda, T., Mandujano-Tinoco, E. A., Tomás, M., Pérez-Eretza, B., García-Contreras, S. J., Wood, T. K., & García-Contreras, R. (2015) · World Journal of Clinical Cases · doi:10.12998/wjcc.v3.i7.575 · Cited by 218
Effective Removal of Staphylococcal Biofilms by the Endolysin LysH5
Gutiérrez, D., Ruas-Madiedo, P., Martínez, B., Rodríguez, A., & García, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107307 · Cited by 217
Hicks, N. D., Yang, J., Zhang, X., Zhao, B., Grad, Y. H., Liu, L., Ou, X., Chang, Z., Xia, H., Zhou, Y., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0218-3 · Cited by 217
Gilmer, D. B., Schmitz, J. E., Euler, C. W., & Fischetti, V. A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02526-12 · Cited by 216
GlpD and PlsB Participate in Persister Cell Formation in Escherichia coli
Spoering, A. L., Vulić, M., & Lewis, K. (2006) · Journal of Bacteriology · doi:10.1128/jb.00369-06 · Cited by 214
Differential regulation by ppGpp versus pppGpp in Escherichia coli
Mechold, U., Potrykus, K., Murphy, H., Murakami, K. S., & Cashel, M. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt302 · Cited by 213
Goormaghtigh, F., Fraikin, N., Putrinš, M., Hallaert, T., Hauryliuk, V., Garcia-Pino, A., Sjödin, A., Kasvandik, S., Udekwu, K., Tenson, T., et al. (2018) · mBio · doi:10.1128/mbio.00640-18 · Cited by 213
Antibiotic tolerance among clinical isolates of bacteria
Tuomanen, E., Durack, D. T., & Tomasz, A. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.30.4.521 · Cited by 212
A NEW TYPE OF PENICILLIN RESISTANCE OF STAPHYLOCOCCUS AUREUS
Sabath, L. D., Laverdiere, M., Wheeler, N., Blazevic, D., & Wilkinson, B. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91941-9 · Cited by 205
Viable but non‐culturable and persistence describe the same bacterial stress state
Kim, J., Chowdhury, N., Yamasaki, R., & Wood, T. K. (2018) · Environmental Microbiology · doi:10.1111/1462-2920.14075 · Cited by 203
Persisters and beyond: Mechanisms of phenotypic drug resistance and drug tolerance in bacteria
Kester, J. C., & Fortune, S. M. (2014) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.869543 · Cited by 202
Efflux pump inhibitors of clinically relevant multidrug resistant bacteria
Lamut, A., Peterlin Mašič, L., Kikelj, D., & Tomašič, T. (2019) · Medicinal Research Reviews · doi:10.1002/med.21591 · Cited by 202
Briers, Y., Walmagh, M., Grymonprez, B., Biebl, M., Pirnay, J.-P., Defraine, V., Michiels, J., Cenens, W., Aertsen, A., Miller, S., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02668-14 · Cited by 200
Correia, F. F., D'Onofrio, A., Rejtar, T., Li, L., Karger, B. L., Makarova, K., Koonin, E. V., & Lewis, K. (2006) · Journal of Bacteriology · doi:10.1128/jb.01237-06 · Cited by 199
What Is the Benefit to Escherichia coli of Having Multiple Toxin-Antitoxin Systems in Its Genome?
Tsilibaris, V., Maenhaut-Michel, G., Mine, N., & Van Melderen, L. (2007) · Journal of Bacteriology · doi:10.1128/jb.00527-07 · Cited by 198
Schuch, R., Lee, H. M., Schneider, B. C., Sauve, K. L., Law, C., Khan, B. K., Rotolo, J. A., Horiuchi, Y., Couto, D. E., Raz, A., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit637 · Cited by 196
Persistent and dormant tubercle bacilli and latent tuberculosis
Zhang, Y. (2004) · Frontiers in Bioscience · doi:10.2741/1291 · Cited by 195
Self-citationCombatting bacterial infections by killing persister cells with mitomycin C
Kwan, B. W., Chowdhury, N., & Wood, T. K. (2015) · Environmental Microbiology · doi:10.1111/1462-2920.12873 · Cited by 193
Targeting Antibiotic Tolerance, Pathogen by Pathogen
Meylan, S., Andrews, I. W., & Collins, J. J. (2018) · Cell · doi:10.1016/j.cell.2018.01.037 · Cited by 193
Automated imaging with ScanLag reveals previously undetectable bacterial growth phenotypes
Levin-Reisman, I., Gefen, O., Fridman, O., Ronin, I., Shwa, D., Sheftel, H., & Balaban, N. Q. (2010) · Nature Methods · doi:10.1038/nmeth.1485 · Cited by 191
De Biase, D., & Pennacchietti, E. (2012) · Molecular Microbiology · doi:10.1111/mmi.12020 · Cited by 188
Heterogeneous bacterial persisters and engineering approaches to eliminate them
Allison, K. R., Brynildsen, M. P., & Collins, J. J. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.09.002 · Cited by 186
General Mechanisms Leading to Persister Formation and Awakening
Wilmaerts, D., Windels, E. M., Verstraeten, N., & Michiels, J. (2019) · Trends in Genetics · doi:10.1016/j.tig.2019.03.007 · Cited by 186
Enhanced respiration prevents drug tolerance and drug resistance in Mycobacterium tuberculosis
Vilchèze, C., Hartman, T., Weinrick, B., Jain, P., Weisbrod, T. R., Leung, L. W., Freundlich, J. S., & Jacobs, W. R. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1704376114 · Cited by 185
Salmonella typhimurium intercepts Escherichia coli signaling to enhance antibiotic tolerance
Vega, N. M., Allison, K. R., Samuels, A. N., Klempner, M. S., & Collins, J. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308085110 · Cited by 184
Mannitol Enhances Antibiotic Sensitivity of Persister Bacteria in Pseudomonas aeruginosa Biofilms
Barraud, N., Buson, A., Jarolimek, W., & Rice, S. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084220 · Cited by 183
Pribis, J. P., García-Villada, L., Zhai, Y., Lewin-Epstein, O., Wang, A. Z., Liu, J., Xia, J., Mei, Q., Fitzgerald, D. M., Bos, J., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.02.037 · Cited by 183
Contribution of Stress Responses to Antibiotic Tolerance in Pseudomonas aeruginosa Biofilms
Stewart, P. S., Franklin, M. J., Williamson, K. S., Folsom, J. P., Boegli, L., & James, G. A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00433-15 · Cited by 182
Borrelia burgdorferi, the Causative Agent of Lyme Disease, Forms Drug-Tolerant Persister Cells
Sharma, B., Brown, A. V., Matluck, N. E., Hu, L. T., & Lewis, K. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00864-15 · Cited by 177
Trastoy, R., Manso, T., Fernández-García, L., Blasco, L., Ambroa, A., Pérez del Molino, M. L., Bou, G., García-Contreras, R., Wood, T. K., & Tomás, M. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00023-18 · Cited by 177
Harrison, J. J., Wade, W. D., Akierman, S., Vacchi-Suzzi, C., Stremick, C. A., Turner, R. J., & Ceri, H. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00043-09 · Cited by 175
Persister Cells in Biofilm Associated Infections
Conlon, B. P., Rowe, S. E., & Lewis, K. (2015) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-09782-4_1 · Cited by 172
Luca, V., Stringaro, A., Colone, M., Pini, A., & Mangoni, M. L. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1291-7 · Cited by 170
Bacterial persistence increases as environmental fitness decreases
Hong, S. H., Wang, X., O'Connor, H. F., Benedik, M. J., & Wood, T. K. (2012) · Microbial Biotechnology · doi:10.1111/j.1751-7915.2011.00327.x · Cited by 169
Glauser, M. P., Bernard, J. P., Moreillon, P., & Francioli, P. (1983) · Journal of Infectious Diseases · doi:10.1093/infdis/147.3.568 · Cited by 168
Vulin, C., Leimer, N., Huemer, M., Ackermann, M., & Zinkernagel, A. S. (2018) · Nature Communications · doi:10.1038/s41467-018-06527-0 · Cited by 167
Ali, L., Goraya, M., Arafat, Y., Ajmal, M., Chen, J.-L., & Yu, D. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18050960 · Cited by 165
Leung, V., & Lévesque, C. M. (2012) · Journal of Bacteriology · doi:10.1128/jb.06707-11 · Cited by 164
Gefen, O., Chekol, B., Strahilevitz, J., & Balaban, N. Q. (2017) · Scientific Reports · doi:10.1038/srep41284 · Cited by 164
Bacteriophage Lysin CF-301, a Potent Antistaphylococcal Biofilm Agent
Schuch, R., Khan, B. K., Raz, A., Rotolo, J. A., & Wittekind, M. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02666-16 · Cited by 164
Singh, R., Barry, C. E., & Boshoff, H. I. (2010) · Journal of Bacteriology · doi:10.1128/jb.01285-09 · Cited by 163
Relacin, a Novel Antibacterial Agent Targeting the Stringent Response
Wexselblatt, E., Oppenheimer-Shaanan, Y., Kaspy, I., London, N., Schueler-Furman, O., Yavin, E., Glaser, G., Katzhendler, J., & Ben-Yehuda, S. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002925 · Cited by 162
Zhang, S., Chen, J., Shi, W., Liu, W., Zhang, W., & Zhang, Y. (2013) · Emerging Microbes & Infections · doi:10.1038/emi.2013.38 · Cited by 160
Self-citationNovel approaches to combat bacterial biofilms
Beloin, C., Renard, S., Ghigo, J.-M., & Lebeaux, D. (2014) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.09.005 · Cited by 160
Efficacy of Artilysin Art-175 against Resistant and Persistent Acinetobacter baumannii
Defraine, V., Schuermans, J., Grymonprez, B., Govers, S. K., Aertsen, A., Fauvart, M., Michiels, J. J., Lavigne, R., & Briers, Y. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00285-16 · Cited by 160
Jennings, M. C., Ator, L. E., Paniak, T. J., Minbiole, K. P. C., & Wuest, W. M. (2014) · ChemBioChem · doi:10.1002/cbic.201402254 · Cited by 159
Viable but Nonculturable and Persister Cells Coexist Stochastically and Are Induced by Human Serum
Ayrapetyan, M., Williams, T. C., Baxter, R., & Oliver, J. D. (2015) · Infection and Immunity · doi:10.1128/iai.00404-15 · Cited by 159
Polyamines in Bacteria: Pleiotropic Effects yet Specific Mechanisms
Wortham, B. W., Oliveira, M., & Patel, C. N. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-72124-8_9 · Cited by 158
ppGpp: stringent response and survival.
Jain, V. P., Kumar, M., & Chatterji, D. (2006) · PubMed · Cited by 158
Antibiotics: Combatting Tolerance To Stop Resistance
Windels, E. M., Michiels, J. E., Van den Bergh, B., Fauvart, M., & Michiels, J. (2019) · mBio · doi:10.1128/mbio.02095-19 · Cited by 158
Antibiotic Synergism Against Listeria monocytogenes
Moellering, R. C., Medoff, G., Leech, I., et al. (1972) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.1.1.30 · Cited by 156
Cited by
Anderson, C. M., Mattenberger, Y., Parga, A., Portalier, H., Tan, C. A. Z., Esteban Henao, M., Viollier, P. H., & Kline, K. A. (2026) · Journal of Bacteriology · doi:10.1128/jb.00548-25 · Cited by 2
Metadata
- Authors
- Niu, H., Gu, J., & Zhang, Y.
- Venue
- Signal Transduction and Targeted Therapy
- Published
- 2024-07-17
- Volume
- 9
- Issue
- 1
- Pages
- 174-174
- ISSN
- 2059-3635 (ISSN-L)
- OpenAlex
- W4400748219
- Cited by
- 310
- References
- 457
- FWCI
- 74.98
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.